Bicara Therapeutics Inc.
BCAX
DELAYED 1 MONTH
19 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 26 9:48 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $20.42 | $187.9K | 145,355(D) | View → |
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 15,000 | $20.04 | $300.6K | 362,152(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $20.29 | $253.6K | 191,641(D) | View → |
| Mar 16, 2026 | Mar 17 9:36 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $19.66 | $245.7K | 200,641(D) | View → |
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 36,766 | $19.17 | $704.7K | 339,392(D) | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 3,817 | $18.75 | $71.6K | 339,392(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 1,786 | $18.74 | $33.5K | 339,392(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 2,631 | $18.73 | $49.3K | 339,392(D) | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Sale | 17,392 | $18.16 | $315.9K | 205,141(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 2,963 | $18.25 | $54.1K | 145,355(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 13,555 | $18.22 | $246.9K | 145,355(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 16,300 | $18.52 | $301.9K | 55,286(D) | View → |
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 200 | $18.45 | $3.7K | 55,286(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 29 8:18 PM | Jeremy BenderDirector | Grant/Award | 38,950 | $26.88 | 38,950(D) | View → |
| Jul 28, 2026 | Jul 29 8:18 PM | Christy J. OligerDirector | Grant/Award | 38,950 | $26.88 | 38,950(D) | View → |
| Jun 9, 2026 | Jun 10 8:43 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 19,475 | $20.56 | 19,475(I) | View → |
| Jun 9, 2026 | Jun 10 8:35 PM | Christopher BowdenDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kate HavilandDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kiran Mazumdar-ShawDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Scott M. RobertsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Michael PowellDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:32 PM | Jake SimsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| May 21, 2026 | May 26 9:48 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 70,584(D) | View → |
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 146,107(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 101,334(D) | View → |
| May 8, 2026 | May 12 8:04 PM | William SchelmanChief Medical Officer | Grant/Award | 85,000 | $22.58 | 85,000(D) | View → |
| Mar 16, 2026 | Mar 17 9:36 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 117,334(D) | View → |
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 36,766 | $3.79 | 191,107(D) | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 3,817 | $3.79 | 227,873(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,786 | $3.79 | 231,690(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 2,631 | $3.79 | 233,476(D) | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Option Exercise | 12,892 | $3.79 | 125,334(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Option Exercise | 2,963 | $3.79 | 79,784(D) | View → |
Page 1 of 2
Next →